Literature DB >> 24006053

Assessment of inflammation with a very small iron-oxide particle in a murine model of reperfused myocardial infarction.

Andrea Protti1, Xuebin Dong, Marcelo E Andia, Bin Yu, Kate Dokukina, Sanjay Chaubey, Alkystis Phinikaridou, Gema Vizcay-Barrena, Matthias Taupitz, Rene M Botnar, Ajay M Shah.   

Abstract

PURPOSE: To investigate a very small iron-oxide particle (VSOP) in a mouse model of acute ischemia-reperfusion to access the mechanism of such particles in areas of myocardial inflammation.
MATERIALS AND METHODS: Animals were injected with VSOP at several time points, in a mouse model of acute myocardial infarction (MI), before and after MI. MRI was used to localize areas of VSOP enhancement, evaluate VSOP areas extension, and determine the related T2* values. Histology, electron microscopy, macrophage counting, and Evan's Blue staining were also performed.
RESULTS: We found that areas of VSOP uptake decreased from 1 to 8 days post-MI while the related T2* values increased. T2* and VSOP areas, defined from MRI data, correlated well between 1 and 3 days post-MI but not at 7 days after injection. Histological analysis and electron microscopy showed colocalization of macrophages with areas of VSOP staining. However, there was no correlation between number of macrophages and the extension of the VSOP areas achieved by MR. We found that only areas of increased permeability (assessed by Evan's Blue staining) showed colocalization of macrophages and VSOP uptake.
CONCLUSION: This study demonstrates that VSOP allows the assessment of myocardial inflammation associated with increased permeability during infarct healing in a mouse model of ischemia-reperfusion.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  MRI; inflammation; iron particles; myocardial infarction

Mesh:

Substances:

Year:  2013        PMID: 24006053     DOI: 10.1002/jmri.24191

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  5 in total

1.  Active targeting theranostic iron oxide nanoparticles for MRI and magnetic resonance-guided focused ultrasound ablation of lung cancer.

Authors:  Zhongling Wang; Ruirui Qiao; Na Tang; Ziwei Lu; Han Wang; Zaixian Zhang; Xiangdong Xue; Zhongyi Huang; Siruo Zhang; Guixiang Zhang; Yuanpei Li
Journal:  Biomaterials       Date:  2017-03-01       Impact factor: 12.479

2.  MK5 haplodeficiency decreases collagen deposition and scar size during post-myocardial infarction wound repair.

Authors:  Sherin Ali Nawaito; Pramod Sahadevan; Marie-Élaine Clavet-Lanthier; Philippe Pouliot; Fatiha Sahmi; Yanfen Shi; Marc-Antoine Gillis; Frederic Lesage; Matthias Gaestel; Martin G Sirois; Angelo Calderone; Jean-Claude Tardif; Bruce G Allen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-03-22       Impact factor: 4.733

Review 3.  The diagnostic value of iron oxide nanoparticles for imaging of myocardial inflammation--quo vadis?

Authors:  Michael Bietenbeck; Anca Florian; Udo Sechtem; Ali Yilmaz
Journal:  J Cardiovasc Magn Reson       Date:  2015-07-08       Impact factor: 5.364

4.  Assessment of Myocardial Remodeling Using an Elastin/Tropoelastin Specific Agent with High Field Magnetic Resonance Imaging (MRI).

Authors:  Andrea Protti; Begoña Lavin; Xuebin Dong; Silvia Lorrio; Simon Robinson; David Onthank; Ajay M Shah; Rene M Botnar
Journal:  J Am Heart Assoc       Date:  2015-08-13       Impact factor: 5.501

5.  Synthesis of europium-doped VSOP, customized enhancer solution and improved microscopy fluorescence methodology for unambiguous histological detection.

Authors:  Angela Ariza de Schellenberger; Ralf Hauptmann; Jason M Millward; Eyk Schellenberger; Yuske Kobayashi; Matthias Taupitz; Carmen Infante-Duarte; Jörg Schnorr; Susanne Wagner
Journal:  J Nanobiotechnology       Date:  2017-10-10       Impact factor: 10.435

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.